Rocket Pharmaceuticals, Inc.

NASDAQ:RCKT

Biotechnology

Healthcare
$2.11 +1.84%

+$0.06 today

Market cap
$235.60M
Beta
0.47
P/E (TTM)
-1.7
EPS (TTM)
-$1.87
52W Low $2.40High $5.45

Volume 1.79M

Average 3.15M

RCKT Net Margin

Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.

No reported Net Margin figures are available to summarize.

Net Margin history

Percent of revenue · from the income statement

No Net Margin data reported for this period type.

Net Margin vs competitors

How RCKT compares with its peers on the latest reported figures

RCKT Competitors Peer median
Net Margin for RCKT and competitors
Company Period LTM level YoY 3-year change
AUTLAutolus Therapeutics plcLTM Mar 2026-312.0% +2330.7 pp+2021.6 pp
QSIQuantum-Si incorporatedLTM Mar 2026-5605.9% -2680.5 pp—
RCKTRocket Pharmaceuticals, Inc.FY2025— ——
LBRXLB Pharmaceuticals Inc Common StockFY2025— ——
SLDBSolid Biosciences Inc.FY2025— ——
AURAAura Biosciences, Inc.FY2025— ——
DSGNDesign Therapeutics, Inc.FY2025— ——
ANNXAnnexon, Inc.FY2025— ——
DBVTDBV Technologies S.A.FY2025— ——
GALTGalectin Therapeutics Inc.FY2025— ——
Peer median (excluding RCKT) -2958.9%-174.9 pp+2021.6 pp

Competitors are the stored peer set for RCKT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue000011.03M
Gross Profit0000(11.03M)
Gross Margin—————
Research & Development125.48M165.57M186.34M171.24M142.02M
Selling, General & Admin41.77M58.77M73.32M101.96M86.5M
Operating Expenses167.25M224.34M259.66M273.21M217.49M
Depreciation & Amortization5.37M6.27M7.1M9.38M11.03M
EBITDA(157.81M)(213.69M)(236.62M)(247.49M)(210.21M)
EBITDA Margin—————
Operating Income(167.25M)(224.34M)(259.66M)(273.21M)(228.52M)
Operating Margin—————
Interest Income3.07M3.89M15.94M18.22M10.62M
Interest Expense5.89M1.91M1.88M1.89M1.89M
Other Income / Expenses(1.82M)2.48M14.06M14.46M5.39M
Income Before Tax(169.07M)(221.86M)(245.6M)(258.75M)(223.12M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(169.07M)(221.86M)(245.6M)(258.75M)(223.12M)
Net Margin—————
EPS (Basic)(2.68)(3.26)(2.92)(2.73)(2.01)
EPS (Diluted)(2.68)(3.26)(2.92)(2.73)(2.01)
Weighted Avg Shares63.24M68.15M84.01M94.81M111.12M
Weighted Avg Shares (Diluted)63.24M68.15M84.01M94.81M111.12M

Rocket Pharmaceuticals, Inc.

NASDAQ:RCKT

Intrinsic Alpha fair value

Locked

Current Price

$2.11

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.